JAK1 and renal cell carcinoma: In summary, our study showed that EHBP1L1 mediates RCC immune escape by preventing JAK1 from ubiquitin‐dependent degradation, thus upregulating the IFN‐γ/JAK1/STAT1 signaling pathway and the transcription of PD‐L1.